Search

All 2
Drugs 1
Targets 0
Indications 1
Pathways 0

Displaying 1 result

DrugBest match

Romidepsin

go.drugbank.com/drugs/DB06176

ApprovedInvestigational

Romidepsin is a selective inhibitor of histone deacetylase, approved in the US in 2009 for the treatment of cutaneous T-cell lymphoma (CTCL) in patients who have received at least one prior systemic therapy.